Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Other Non-Current Liabilities: 2022-2025

Historic Other Non-Current Liabilities for Immunocore Holdings (IMCR) over the last 2 years, with Sep 2025 value amounting to $96.6 million.

  • Immunocore Holdings' Other Non-Current Liabilities rose 3113.71% to $96.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $96.6 million, marking a year-over-year increase of 3113.71%. This contributed to the annual value of $978,000 for FY2023, which is 55.85% down from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Other Non-Current Liabilities is $96.6 million, which was up 15.06% from $84.0 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Other Non-Current Liabilities high stood at $96.6 million for Q3 2025, and its period low was $978,000 during Q4 2023.
  • For the 3-year period, Immunocore Holdings' Other Non-Current Liabilities averaged around $35.9 million, with its median value being $3.0 million (2024).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 55.85% in 2023, then soared by 3,919.15% in 2025.
  • Immunocore Holdings' Other Non-Current Liabilities (Quarterly) stood at $2.2 million in 2022, then crashed by 55.85% to $978,000 in 2023, then reached $3.0 million in 2024, then spiked by 3,113.71% to $96.6 million in 2025.
  • Its Other Non-Current Liabilities was $96.6 million in Q3 2025, compared to $84.0 million in Q2 2025 and $62.5 million in Q1 2025.